헤론 테라퓨틱스(HRTX)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.31 (-1.90%), 시가총액 $0.16B, 52주 최저~최고 $0.75 ~ $2.23.
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a
헤론 테라퓨틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
헤론 테라퓨틱스의 현재 주가는 $0.31 (-1.90%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
헤론 테라퓨틱스의 시가총액은 약 $0.16B입니다.
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its propr